DM
VYGR icon

Deerfield Management’s Voyager Therapeutics VYGR Stock Holding History

Deerfield Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-32,005
Closed -$298K – 571
2024
Q1 		$298K Buy
32,005
+16,518
+107% +$139K 0.01% 256
2023
Q4 		$131K Buy
+15,487
New +$112K ﹤0.01% 196
2019
Q1 		– Sell
-117,647
Closed -$1.11M – 105
2018
Q4 		$1.11M Hold
117,647
– – 0.04% 94
2018
Q3 		$2.23M Hold
117,647
– – 0.08% 98
2018
Q2 		$2.3M Hold
117,647
– – 0.08% 109
2018
Q1 		$2.21M Hold
117,647
– – 0.08% 110
2017
Q4 		$1.95M Hold
117,647
– – 0.08% 92
2017
Q3 		$2.42M Hold
117,647
– – 0.11% 88
2017
Q2 		$1.05M Hold
117,647
– – 0.06% 83
2017
Q1 		$1.56M Sell
117,647
-117,647
-50% -$1.43M 0.06% 101
2016
Q4 		$3M Hold
235,294
– – 0.12% 83
2016
Q3 		$2.83M Hold
235,294
– – 0.13% 75
2016
Q2 		$2.59M Hold
235,294
– – 0.1% 82
2016
Q1 		$2.05M Hold
235,294
– – 0.09% 87
2015
Q4 		$5.15M Buy
+235,294
New +$5.42M 0.21% 82

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Deerfield Management's VYGR Position: Q2 2024 in Review

Deerfield Management sold out of Voyager Therapeutics (VYGR) in Q2 2024, closing a stake of 32,005 shares — an estimated $298K sold.

Deerfield Management first reported a position in VYGR in Q4 2015 and held it in 15 quarters. The position peaked at $5.15M in Q4 2015. 127 funds tracked by Wall St. Rank hold VYGR as of Q2 2024.

  • Deerfield Management reported no remaining Voyager Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Deerfield Management sold 32,005 Voyager Therapeutics shares in Q2 2024, an estimated $298K.
  • Deerfield Management first reported a position in Voyager Therapeutics in Q4 2015 and held it in 15 quarters.
  • Deerfield Management's Voyager Therapeutics position peaked at $5.15M in Q4 2015.
  • 127 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2024.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.